Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...
Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...
Alzheimer's disease researchers say they've built a method using simple blood tests to predict if and when someone may show ...
WPI researchers use machine learning and brain scans to identify age- and sex-specific anatomical patterns that predict ...
What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...
Accumulation of the protein tau in the brain is one of the hallmarks of Alzheimer's disease. In a paper published in Cell ...
While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting ...
Last year, the National Institute of Health and Care Excellence (Nice) rejected the NHS rollout of the first two drugs – lecanemab and donanemab – that were found to halt the progression of disease.
Scientists have developed a blood test that could predict Alzheimer's symptoms years in advance using p-tau217 protein levels ...
For over thirty years, researchers have primarily studied the accumulation of amyloid beta proteins in the brains of Alzheimer’s patients. They also focus on how that component negatively impacts ...
The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using ...
New noninvasive tools reveal that subtle shifts in brain blood flow and oxygen use may mirror key markers of Alzheimer’s risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results